nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells
|
Mishra, Hemant K. |
|
2018 |
67 |
9 |
p. 1407-1416 |
artikel |
2 |
Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab
|
Putzu, Carlo |
|
2018 |
67 |
9 |
p. 1349-1353 |
artikel |
3 |
CD11c+ MHCIIlo GM-CSF-bone marrow-derived dendritic cells act as antigen donor cells and as antigen presenting cells in neoepitope-elicited tumor immunity against a mouse fibrosarcoma
|
Ebrahimi-Nik, Hakimeh |
|
2018 |
67 |
9 |
p. 1449-1459 |
artikel |
4 |
Correction to: High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer
|
Okuma, Yusuke |
|
2018 |
67 |
9 |
p. 1477-1479 |
artikel |
5 |
Fulminant onset of insulin-dependent diabetes with positive anti-GAD antibody titers during treatment with nivolumab in a patient with NSCLC
|
Matsuura, Nobuko |
|
2018 |
67 |
9 |
p. 1417-1424 |
artikel |
6 |
Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette–Guerin for patients with non-muscle invasive bladder cancer
|
Obara, Wataru |
|
|
67 |
9 |
p. 1371-1380 |
artikel |
7 |
Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette–Guerin for patients with non-muscle invasive bladder cancer
|
Obara, Wataru |
|
2018 |
67 |
9 |
p. 1371-1380 |
artikel |
8 |
Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer
|
Barrera, Lourdes |
|
2018 |
67 |
9 |
p. 1393-1406 |
artikel |
9 |
mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells
|
Deng, Yuting |
|
2018 |
67 |
9 |
p. 1355-1364 |
artikel |
10 |
Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells
|
Sköld, Annette E. |
|
2018 |
67 |
9 |
p. 1425-1436 |
artikel |
11 |
Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer
|
Parikh, Kaushal |
|
2018 |
67 |
9 |
p. 1365-1370 |
artikel |
12 |
Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma
|
Gargett, Tessa |
|
2018 |
67 |
9 |
p. 1461-1472 |
artikel |
13 |
Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma
|
Gargett, Tessa |
|
|
67 |
9 |
p. 1461-1472 |
artikel |
14 |
Potentiation of PD-L1 blockade with a potency-matched dual cytokine–antibody fusion protein leads to cancer eradication in BALB/c-derived tumors but not in other mouse strains
|
De Luca, Roberto |
|
2018 |
67 |
9 |
p. 1381-1391 |
artikel |
15 |
Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing
|
Trabbic, Kevin R. |
|
2018 |
67 |
9 |
p. 1437-1447 |
artikel |
16 |
“Pseudoprogression”: more than semantics
|
Dutcher, Janice P. |
|
2018 |
67 |
9 |
p. 1473-1474 |
artikel |
17 |
Reply to “Pseudoprogression”: more than semantics
|
Wong, Alvin S. |
|
2018 |
67 |
9 |
p. 1475 |
artikel |
18 |
Targeting tumor-associated acidity in cancer immunotherapy
|
Lacroix, Ruben |
|
2018 |
67 |
9 |
p. 1331-1348 |
artikel |